LUNG CANCER, NONSMALL CELL
Clinical trials for LUNG CANCER, NONSMALL CELL explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER, NONSMALL CELL trials appear
Sign up with your email to follow new studies for LUNG CANCER, NONSMALL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may tailor immunotherapy for lung cancer patients after surgery
Disease control Recruiting nowThis study tests whether a blood test that detects tiny bits of tumor DNA (ctDNA-MRD) can help decide who needs immunotherapy after lung cancer surgery. About 80 adults with stage IB-IIIA non-small-cell lung cancer will receive toripalimab, but only if the blood test suggests the…
Matched conditions: LUNG CANCER, NONSMALL CELL
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
New combo tackles lung cancer after immunotherapy fails
Disease control Recruiting nowThis study tests whether adding tocilizumab to atezolizumab can help control advanced non-small cell lung cancer in people whose cancer stopped responding to initial immunotherapy. About 28 adults with stage IV or recurrent disease will receive the combination. The goal is to see…
Matched conditions: LUNG CANCER, NONSMALL CELL
Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
12,000 patients to help unlock secrets of lung cancer treatment
Knowledge-focused Recruiting nowThis study aims to collect health information from 12,000 adults with lung or other chest cancers. Researchers want to understand why some people respond better to treatments than others, by looking at factors like genetics, lifestyle, and tumor details. The goal is to improve fu…
Matched conditions: LUNG CANCER, NONSMALL CELL
Sponsor: Dutch Society of Physicians for Pulmonology and Tuberculosis • Aim: Knowledge-focused
Last updated Apr 24, 2026 16:17 UTC